Hagens Berman Alerts Investors in AbbVie Inc. (ABBV) to the Firm's Investigation of Possible Humira-Related Health Insurance Fraud and Disclosure Violations

Author's Avatar
Sep 22, 2018
Article's Main Image

PR Newswire